220 related articles for article (PubMed ID: 34020641)
21. Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.
Keller T; Spece LJ; Donovan LM; Udris E; Coggeshall SS; Griffith M; Bryant AD; Casaburi R; Cooper JA; Criner GJ; Diaz PT; Fuhlbrigge AL; Gay SE; Kanner RE; Martinez FJ; Panos RJ; Shade D; Sternberg A; Stibolt T; Stoller JK; Tonascia J; Wise R; Yusen RD; Au DH; Feemster LC
Chest; 2020 Aug; 158(2):529-538. PubMed ID: 32278779
[TBL] [Abstract][Full Text] [Related]
22. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
23. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.
Kiser TH; Allen RR; Valuck RJ; Moss M; Vandivier RW
Am J Respir Crit Care Med; 2014 May; 189(9):1052-64. PubMed ID: 24617842
[TBL] [Abstract][Full Text] [Related]
24. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
25. Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD: A Prospective, Multicenter, Randomized, Open-Label Clinical Trial.
Li L; Zhao N; Ma X; Sun F; He B; Qin Z; Wu K; Wang X; Zhao Q; Zhang S; Nie N; Luo D; Sun B; Shen Y; He Y; Wen F; Zheng J; Jones P; Cao G
Chest; 2021 Nov; 160(5):1660-1669. PubMed ID: 34023318
[TBL] [Abstract][Full Text] [Related]
26. Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study.
Zhang J; Zheng J; Huang K; Chen Y; Yang J; Yao W
Ther Adv Respir Dis; 2018; 12():1753466618769514. PubMed ID: 29692212
[TBL] [Abstract][Full Text] [Related]
27. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH
Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798
[TBL] [Abstract][Full Text] [Related]
28. Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease?
Vondracek SF; Hemstreet BA
Pharmacotherapy; 2006 Apr; 26(4):522-32. PubMed ID: 16553512
[TBL] [Abstract][Full Text] [Related]
29. Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Zhang R; Zhu J; Liu Y; Li Y; Liu W; Zhang M; Chen B; Zhu S
Int J Chron Obstruct Pulmon Dis; 2020; 15():409-415. PubMed ID: 32161453
[TBL] [Abstract][Full Text] [Related]
30. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
JAMA; 2018 Oct; 320(15):1548-1559. PubMed ID: 30326124
[TBL] [Abstract][Full Text] [Related]
31. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Walters JA; Gibson PG; Wood-Baker R; Hannay M; Walters EH
Cochrane Database Syst Rev; 2009 Jan; (1):CD001288. PubMed ID: 19160195
[TBL] [Abstract][Full Text] [Related]
32. Determinants of exacerbation risk in patients with COPD in the TIOSPIR study.
Calverley PM; Tetzlaff K; Dusser D; Wise RA; Mueller A; Metzdorf N; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2017; 12():3391-3405. PubMed ID: 29238184
[TBL] [Abstract][Full Text] [Related]
33. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease.
Lindenauer PK; Pekow PS; Lahti MC; Lee Y; Benjamin EM; Rothberg MB
JAMA; 2010 Jun; 303(23):2359-67. PubMed ID: 20551406
[TBL] [Abstract][Full Text] [Related]
34. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
Vogelmeier C; Worth H; Buhl R; Criée CP; Lossi NS; Mailänder C; Kardos P
Int J Chron Obstruct Pulmon Dis; 2017; 12():487-494. PubMed ID: 28203072
[TBL] [Abstract][Full Text] [Related]
35. Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
Devereux G; Cotton S; Barnes P; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Fielding S; Gompertz S; Haughney J; Lee AJ; McCormack K; McPherson G; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Trials; 2015 Jun; 16():267. PubMed ID: 26058585
[TBL] [Abstract][Full Text] [Related]
36. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
[TBL] [Abstract][Full Text] [Related]
37. Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial.
Zhang H; Li J; Yu X; Li S; Wang H; Ruan H; Si Y; Xie Y; Wang M
Trials; 2019 Dec; 20(1):735. PubMed ID: 31842969
[TBL] [Abstract][Full Text] [Related]
38. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
[TBL] [Abstract][Full Text] [Related]
39. Effects of air pollution on acute exacerbation of chronic obstructive pulmonary disease: a descriptive retrospective study (pol-AECOPD).
Morantes-Caballero JA; Fajardo Rodriguez HA
Int J Chron Obstruct Pulmon Dis; 2019; 14():1549-1557. PubMed ID: 31371940
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and Safety Comparison for Systemic Corticosteroid Therapy With and Without Inhaled Corticosteroids for COPD Exacerbation Management.
Pearce JA; Shiltz DL; Ding Q
Ann Pharmacother; 2018 Nov; 52(11):1070-1077. PubMed ID: 29783858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
